Tested in animal models of acute myeloid leukemia, the new nanomedicine was dramatically more effective while also less toxic.

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...

A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

The results could help expand use of Welireg, one of the medicines Merck is counting on to drive revenue growth when its ...

Iovance Biotherapeutics shares rose after the company received positive data from a clinical trial of its cancer treatment. Shares traded 11% higher ahead of the morning bell at $2.18.

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...

FIRST CLINICAL TRIAL OF A NEW CANCER DRUG FOR CATS. AND IT COULD HAVE APPLICATIONS FOR HUMANS. YEAH, IT’S INTERESTING. SCIENTISTS AT UC DAVIS AND UC SAN FRANCISCO HAVE TREATED CATS WITH SQUAMOUS CELL ...

Trump’s intervention on behalf of the ‘Dilbert’ creator and MAGA supporter sparked a range of reactions online.